THE WOODLANDS, TX--(Marketwired - May 8, 2014) - UniPixel, Inc. (
Q1 2014 Highlights
- Finalized the base catalytic ink and confirmed production scale performance at the Kodak Rochester facility, a state-of-the-art manufacturing and testing facility within the Eastman Business Park in Rochester, New York.
- Established new product and technology roadmap for the company's touch screen technology.
- Based on new roadmap, technical work streams now focused on development project to produce an initial product for the tablet market.
- Engaged a development customer for the tablet touch screen product development.
"During the first quarter, UniPixel made good progress toward overcoming certain challenges necessary to complete the manufacturing process for our flagship touch screen technology, particularly as it relates to ink and printing," said Jeff Hawthorne, recently appointed president and CEO of UniPixel.
"A significant focus of our development effort has now turned to the critical process of plating the conductive materials on a roll-to-roll basis," continued Hawthorne. "Our lab-based single sensor batch plating process that we have used for proof of concept, sample units and low volume customer orders has been robust and with relatively high yields. However, the roll-to-roll plating process still requires modifications and adjustments to hardware, geometry and chemistry in order to produce yields at our target production levels. To this end, we have teams pursuing several parallel development paths to improve the roll-to-roll plating process.
"Another significant reason for why a baseline manufacturing process has taken longer than initially planned is because of the additional complexity created by multiple teams developing technology and manufacturing process for a full range of products, from Smartphone, tablet and notebook to all-in-one product applications. To reduce the complexity and speed our time-to-market, we have now focused our technical work streams on a development project to produce an initial product for the tablet market. We have also engaged a development customer for this product. After this initial product launch, we plan to follow a newly established product and technology roadmap that addresses the other touch-screen market segments.
"With our new product roadmap and initial product development focus strategy, I am confident that our development team, working closely with Kodak, will overcome in due course the remaining technical hurdles to achieve a reliable, high-volume, roll-to-roll production process for our projected capacitive, multi-touch sensor films.
"As we've mentioned earlier, we anticipate achieving certain progress milestones in the second quarter of 2014 that will enhance our outlook regarding the exact timing around volume commercial shipments of our touch screens, and we plan to report on these and other product activities as they develop."
Q1 2014 Financial Summary
In the first quarter of 2014, the company did not generate revenues as it focused on manufacturing process development. This compares to revenue of $5.1 million in the first quarter of 2013, which was primarily due to a $5.0 million payment received by the company's PC OEM licensee.
Selling, general and administrative (SG&A) expenses totaled $2.9 million in the first quarter of 2014, as compared to $2.2 million in the same year-ago quarter. The increase was primarily due to an increase in depreciation and amortization expenses, as well as partially driven by an increase in the number of employees. The increase in SG&A was partially offset by decreases in legal expense and bonus accrual, as well as decreases in stock compensation expense and restricted stock expense attributable to SG&A.
Research and development expenses totaled $3.3 million in the first quarter of 2014, as compared to $1.9 million in the first quarter of 2013. The increase was primarily due to increased lab expense related to prototype development of products based on the company's performance engineered films, as well as partially driven by an increase in the number of employees, as well as increases in stock compensation expense and restricted stock expense attributable to research and development. The increase in research and development expense was partial offset by a decrease in related bonus accrual.
Net loss was $6.2 million or $(0.50) per basic and diluted share in the first quarter of 2014, as compared to net income of $0.9 million or $0.07 per diluted share in the same year-ago period.
Cash and cash equivalents totaled $34.4 million at March 31, 2014, as compared to $39.4 million at December 31, 2013.
UniPixel management will host a conference call later today to discuss the first quarter of 2014 and the outlook for the year, followed by a question and answer period.
The call will be webcast live here, as well as via a link in the Investors section of the company's website at www.unipixel.com/investors. Webcast participants will be able to submit a question to management via the webcast player.
Date: Thursday, May 8, 2014
Time: 4:30 p.m. Eastern time (3:30 p.m. Central time)
To participate in the conference call via telephone, dial 1-480-629-9857 and provide the conference name or conference ID 4680250. Please call the conference telephone number 5-10 minutes prior to the start time so the operator can register your name and organization.
If you have any difficulty with the webcast or connecting to the call, please contact Liolios Group at 1-949-574-3860.
A replay of the call will be available after 7:30 p.m. Eastern time on the same day through June 8, 2014, via the same link above, or by dialing 1-858-384-5517 and entering replay ID 4680250.
Headquartered in The Woodlands, Texas, UniPixel, Inc. (
All statements in this news release that are not based on historical fact are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. While management has based any forward-looking statements contained herein on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties, and other factors, many of which are outside of our control that could cause actual results to materially differ from such statements. Such risks, uncertainties, and other factors include, but are not necessarily limited to, those set forth under Item 1A "Risk Factors" in the companies' respective Annual Report on Form 10-K for the year ended December 31, 2013. We operate in a highly competitive and rapidly changing environment, thus new or unforeseen risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. We disclaim any intention to, and undertake no obligation to, update or revise any forward-looking statements. Readers are also urged to carefully review and consider the other various disclosures in the companies' respective Annual Report on Form 10-K, quarterly reports on Form 10-Q and Current Reports on Form 8-K.
Trademarks in this release are the property of their respective owners.
|Condensed Consolidated Balance Sheets|
|March 31, 2014||December 31, |
|Cash and cash equivalents||$||34,364,740||$||39,369,574|
|Account receivable, net||--||11,409|
|Total current assets||34,364,740||39,380,983|
|Property and equipment, net of accumulated depreciation of $6,272,171 and $4,769,453, at March 31, 2014 and December 31, 2013, respectively||15,001,389||15,893,435|
|LIABILITIES AND SHAREHOLDERS' EQUITY|
|Total current liabilities||5,504,786||6,053,748|
|Commitments and contingencies||--||--|
|Common stock, $0.001 par value; 100,000,000 shares authorized, 12,349,047 shares issued and outstanding at March 31, 2014 and 12,244,714 shares issued and outstanding at December 31, 2013||12,349||12,245|
|Additional paid-in capital||136,548,827||135,720,308|
|Total shareholders' equity||43,878,782||49,238,109|
|Total liabilities and shareholders' equity||$||49,383,568||$||55,291,857|
|Condensed Consolidated Statements of Operations|
|Three Months Ended |
|Cost of revenues||--||3,036|
|Selling, general and administrative expenses||2,868,404||2,180,067|
|Research and development||3,324,346||1,939,888|
|Operating income (loss)||(6,192,750||)||946,425|
|Interest income, net||4,800||990|
|Net income (loss)||$||(6,187,950||)||$||947,415|
|Per share information|
|Net income (loss) - basic||$||(0.50||)||$||0.09|
|Net income (loss) - diluted||(0.50||)||0.07|
|Weighted average number of basic common shares outstanding||12,273,772||10,068,092|
|Weighted average number of diluted common shares outstanding||12,273,772||12,865,361|